PMID- 21477953 OWN - NLM STAT- MEDLINE DCOM- 20111014 LR - 20211203 IS - 1873-2232 (Electronic) IS - 0378-4320 (Linking) VI - 125 IP - 1-4 DP - 2011 May TI - Activation of PI3K/mTOR signaling pathway contributes to induction of vascular endothelial growth factor by hCG in bovine developing luteal cells. PG - 42-8 LID - 10.1016/j.anireprosci.2011.03.002 [doi] AB - We recently reported that HIF-1alpha plays a critical role in the regulation of vascular endothelial growth factor (VEGF) expression in the developing letual cells (LCs) and VEGF-dependent angiogenesis is essential for normal luteal development. Although it is believed that hypoxia is the primary inducer of VEGF, recent reports have also shown that human chorionic gonadotrophin (hCG) up-regulates VEGF expression in developing corpus luteum (CL). Therefore the present study was designed to test the induced effects of hCG on the expression of VEGF and HIF-1alpha in LCs under normoxic and hypoxic conditions. In addition, we also investigated whether the signaling pathways such as phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) and mitogen-activated protein kinase (MAPK) are involved in hCG-induced VEGF in LCs. A significant increase of VEGF mRNA was found in LCs treated with hCG, which was consistent with the changes of HIF-1alpha protein, even under hypoxic conditions. However, there was no obvious changes of HIF-1alpha mRNA in hCG-treated LCs between normoxic and hypoxic conditions, indicating hCG induces VEGF expression by increasing transcription of HIF-1alpha, while hypoxia mainly increases HIF-1alpha protein stability. When LCs were pretreated with inhibitors, we found that the PI3K/mTOR signaling pathway is required for HIF-1alpha and VEGF expression induced by hCG, while the MAPK pathway is not required. Together, these results suggest that activation of IP3K/mTOR signaling pathway contributes to the induction of VEGF and HIF-1alpha in hCG-treated LCs. To our knowledge this will provide a new insight into the important mechanism of hCG/LH-induced VEGF-dependent angiogenesis in the bovine ovary. CI - Copyright (c) 2011 Elsevier B.V. All rights reserved. FAU - Zhang, Zhenghong AU - Zhang Z AD - Department of Animal Science, College of Animal Science and Technology, Anhui Science and Technology University, Bengbu 233100, China. FAU - Yu, Debing AU - Yu D FAU - Yin, Dingzhong AU - Yin D FAU - Wang, Zhengchao AU - Wang Z LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110315 PL - Netherlands TA - Anim Reprod Sci JT - Animal reproduction science JID - 7807205 RN - 0 (Chorionic Gonadotropin) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Phosphoinositide-3 Kinase Inhibitors) RN - 0 (Protein Kinase Inhibitors) RN - 0 (Vascular Endothelial Growth Factor A) RN - 63231-63-0 (RNA) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Animals MH - Blotting, Western/veterinary MH - Cattle/*physiology MH - Chorionic Gonadotropin/*pharmacology MH - Corpus Luteum/cytology/drug effects/enzymology/*metabolism MH - Enzyme Activation/drug effects MH - Female MH - Hypoxia-Inducible Factor 1, alpha Subunit/biosynthesis/genetics MH - Luteal Cells/drug effects/enzymology/*metabolism MH - Phosphatidylinositol 3-Kinases/*metabolism MH - Phosphoinositide-3 Kinase Inhibitors MH - Protein Kinase Inhibitors/pharmacology MH - RNA/chemistry/genetics MH - Reverse Transcriptase Polymerase Chain Reaction/veterinary MH - Signal Transduction/drug effects MH - TOR Serine-Threonine Kinases/*metabolism MH - Vascular Endothelial Growth Factor A/*biosynthesis/genetics EDAT- 2011/04/12 06:00 MHDA- 2011/10/15 06:00 CRDT- 2011/04/12 06:00 PHST- 2010/08/09 00:00 [received] PHST- 2011/02/28 00:00 [revised] PHST- 2011/03/07 00:00 [accepted] PHST- 2011/04/12 06:00 [entrez] PHST- 2011/04/12 06:00 [pubmed] PHST- 2011/10/15 06:00 [medline] AID - S0378-4320(11)00072-8 [pii] AID - 10.1016/j.anireprosci.2011.03.002 [doi] PST - ppublish SO - Anim Reprod Sci. 2011 May;125(1-4):42-8. doi: 10.1016/j.anireprosci.2011.03.002. Epub 2011 Mar 15.